Building employee participation and forming good habits contribute to a company-wide quality culture that pays off.
Managing people—and establishing a culture that promotes quality, is challenging for scientists and engineers in the pharmaceutical industry who are accustomed to functions that can be measured. Managing and developing quality concepts that are not readily measured can be difficult.
A case study shows how embedding quality habits into employees helps them do a task right the first time by off-loading routine good manufacturing practices from their conscious to unconscious mind. The result can be the establishment of desirable quality habits for members of the organization.
Read this article in BioPharm International’s Regulatory Sourcebook October 2020 eBook.
BioPharm International
eBook: Regulatory Sourcebook
October 2020
Pages: 50–53
When referring to this article, please cite it as N. Howe, “Strong Quality Culture: A How-To for Busy Managers," BioPharm International Regulatory Sourcebook eBook (October 2020).
Regeneron Treatment for Multiple Myeloma Gets Conditional Marketing Approval from EC
April 29th 2025The indication is specific to patients who have received at least three prior therapies, including a proteasome inhibitor, immunomodulatory agent, and anti-CD38 monoclonal antibody, and have demonstrated disease progression on the last therapy.
MHRA Approves GSK Therapy Combinations for Multiple Myeloma
April 21st 2025Belantamab mafodotin is approved in combination with bortezomib plus dexamethasone in patients who have had at least one prior therapy, and in combination with pomalidomide plus dexamethasone for those who have had a prior therapy including lenalidomide.